Frauke Hein

Chief Executive Officer at SCIENION
  • Claim this Profile
Contact Information
us****@****om
(386) 825-5501
Location
Germany, DE

Topline Score

Topline score feature will be out soon.

Bio

Generated by
Topline AI

You need to have a working account to view this content.
You need to have a working account to view this content.

Experience

    • Germany
    • Biotechnology Research
    • 1 - 100 Employee
    • Chief Executive Officer
      • Jun 2022 - Present

      Germany

    • Germany
    • Research Services
    • 1 - 100 Employee
    • Advisory Board Member
      • Apr 2021 - Present

      Jena, Thuringia, Germany

    • Germany
    • Newspaper Publishing
    • Jury Member Healthcare, Berlin Brandenburg Region Innovation Award
      • Jun 2019 - Present

      Berlin, Germany

    • Board Member
      • Mar 2015 - Present

      Jena, Thuringia, Germany

    • Netherlands
    • Hospitals and Health Care
    • 1 - 100 Employee
    • Venture Advisor
      • Jan 2021 - Jul 2022

      Amsterdam, The Netherlands

    • Germany
    • Pharmaceutical Manufacturing
    • 1 - 100 Employee
    • Chief Business Officer and cofounder
      • Sep 2011 - Jun 2022

      Hennigsdorf, bei Berlin Heading and executing all strategic, marketing and business development / licensing activities leading to the vision to become a leader in targeting vascular integrity for treating life threatening diseases. In charge of for biopharma partnering and alliance management, IR and corporate communication strategy. In that position I am overseeing company business planning and execution, defining the company and product positioning and strategic R&D direction. Succesfully fundraising of >60 Mio€ .

    • Director Portfolio Management
      • Sep 2011 - Sep 2017

      Berlin

    • United States
    • Biotechnology Research
    • 700 & Above Employee
    • Director Project Coordination R&D
      • Oct 2009 - Aug 2011

      Hennigsdorf Chross-functional leadeship role. In charge of R&D controlling. Leading the project team for the launch of B·R·A·H·M·S Copeptin proAVP KRYPTOR, an automated test for early rule out of myocardial infarction. Initiation and securing the funding of a telemedicine project (FONTANE) for validation of the biomarker adrenomedullin as short term risk monitoring tool in heart failure outpatients (“Point ofCare@Home”).

    • Germany
    • Medical Equipment Manufacturing
    • 1 - 100 Employee
    • Director Research & Development
      • Sep 2007 - Sep 2009

      Hennigsdorf, Germany Chross functional project coordination of R&D Department. Responsible for financial and strategic planning, budgeting and coordination of global R&D projects in the field of biomarkers in cardiology, liver disease, sepsis and neurodegeneration. Initiation and assessment of new disease areas. KOL Management.

    • Germany
    • Business Consulting and Services
    • 1 - 100 Employee
    • Director Life Science
      • Jan 2001 - Aug 2007

      Potsdam Area, Germany ZAB Brandenburg Economic Development Board Building up and leading a team responsible for assessment and managing of research and product development grants of life science companies in Brandenburg. Advising financing and strategic planning for innovative bio-/medtec start-ups. Technology and market assessment for Venture Capital.

    • Project Manager Biotechnology
      • Apr 2000 - Dec 2000

      Potsdam Area, Germany Merged with WfBB to ZAB Bandendurg Economic Development Board Technology and market assessment of Biotech / Mectech R&D Projects of Companies in the state of Brandenburg

Education

  • University of Münster
    Doctor of Philosophy - PhD, Biotechnology and Biochemistry of Plants
    1995 - 2000
  • University of Münster
    Diploma in Biology
    1989 - 1995

Community

You need to have a working account to view this content. Click here to join now